Compounds of formula (I) in free or salt or solvate form, wherein X, T1, T3 and T4 have the meanings as indicated in the specification, are useful for treating diseases mediated by the ALK-5 and/or ALK-4 receptor. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
申请公布号
WO2009087225(A2)
申请公布日期
2009.07.16
申请号
WO2009EP50225
申请日期
2009.01.09
申请人
NOVARTIS AG;LEBLANC, CATHERINE;PULZ, ROBERT ALEXANDER;STIEFL, NIKOLAUS JOHANNES
发明人
LEBLANC, CATHERINE;PULZ, ROBERT ALEXANDER;STIEFL, NIKOLAUS JOHANNES